Brief: Living Cell Technologies Signs Services Agreement With New Zealand Biotech Nzeno Limited
Jan 24 (Reuters) - Living Cell Technologies Ltd LCT.AX :
* SIGNS SERVICES AGREEMENT WITH NEW ZEALAND BIOTECH NZENO
LIMITED
* AGREEMENT TO OBTAIN TISSUE FROM PATHOGEN-FREE PIGS FOR
THIRD
CLINICAL TRIAL OF NTCELL
Source text for Eikon: ID:nASX8FSpWm
Further company coverage: LCT.AX
((reuters.briefs@thomsonreuters.com;))
Recent news on Algorae Pharmaceuticals
See all newsAlgorae Pharmaceuticals rises on Australian distribution deal with India's Umedica
Brief: Algorae Pharmaceuticals Executes Licence & Supply Agreement With Umedica
Australia's Algorae Pharmaceuticals gains on Peter MacCallum Cancer Centre partnership
Brief: Algorae Pharmaceuticals Partners With Peter Maccallum Cancer Centre
Brief: Algorae Pharmaceuticals Named Launch Partner In Sovereign Ai Infrastructure Initiative